Tasigna Atherosclerosis Risks Concealed from Doctors, Patients in U.S.: Lawsuit
Plaintiff had to undergo four coronary artery bypass grafts due to Tasigna atherosclerosis risks, the lawsuit states.
Plaintiff had to undergo four coronary artery bypass grafts due to Tasigna atherosclerosis risks, the lawsuit states.
Doctors often wait longer to refer female patients for coronary artery bypass grafting (CABG) surgery, resulting in them facing a significantly increased risk of complications and death
Side effects of Brilinta tripled the risk of significant bleeding events following coronary artery bypass, although the blood thinner did decrease the risk of vein graft failure
Pfizer allegedly knew about the blood clot risks with Xeljanz, but misled patients and the medical community in order to maximize profits.